OKYO Pharma OKYO
NASDAQ OKYO
$1.59 +0.22 (+16.01%)
As of: Oct 21, 2026 · 12:58 PM EDT

OKYO Pharma (OKYO) Intangibles (2021)

Updated

Analysis

OKYO Pharma (OKYO) Intangibles (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Intangibles (Qtr)
1 Eli Lilly 1,134.62 Bn 1,103.20 Bn 19.71 Bn 18.11 Bn
2 Johnson & Johnson 616.94 Bn 535.47 Bn 17.26 Bn 48.23 Bn
3 AbbVie 501.32 Bn 474.43 Bn 12.70 Bn 49.14 Bn
4 Merck 367.44 Bn 321.82 Bn 12.21 Bn 24.98 Bn
5 Novartis Ag 298.20 Bn 262.19 Bn 11.24 Bn 42.07 Bn
6 Astrazeneca 261.78 Bn 235.47 Bn 12.86 Bn 37.72 Bn
7 Amgen 235.70 Bn 191.10 Bn 7.24 Bn 20.49 Bn
8 Gilead Sciences 190.88 Bn 165.07 Bn 6.22 Bn 14.03 Bn
9 Pfizer 169.72 Bn 116.36 Bn 10.94 Bn 47.05 Bn
10 OKYO Pharma 1.07 Bn 1.04 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 98.58 Bn
API Access

OKYO Pharma Intangibles API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=intangibles&ticker=OKYO&period=max&api_key=YOUR_API_KEY